{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:04:15Z","timestamp":1785294255278,"version":"3.55.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["3S031319"],"award-info":[{"award-number":["3S031319"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["11B4518N"],"award-info":[{"award-number":["11B4518N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["12E9716N"],"award-info":[{"award-number":["12E9716N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007229","name":"Bijzonder Onderzoeksfonds UGent","doi-asserted-by":"publisher","award":["BOF20DOC220"],"award-info":[{"award-number":["BOF20DOC220"]}],"id":[{"id":"10.13039\/501100007229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012331","name":"Agentschap Innoveren en Ondernemen","doi-asserted-by":"publisher","award":["SB-141209"],"award-info":[{"award-number":["SB-141209"]}],"id":[{"id":"10.13039\/100012331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Toxicoepigenetics is an emerging field that studies the toxicological impact of compounds on protein expression through heritable, non-genetic mechanisms, such as histone post-translational modifications (hPTMs). Due to substantial progress in the large-scale study of hPTMs, integration into the field of toxicology is promising and offers the opportunity to gain novel insights into toxicological phenomena. Moreover, there is a growing demand for high-throughput human-based in vitro assays for toxicity testing, especially for developmental toxicity. Consequently, we developed a mass spectrometry-based proof-of-concept to assess a histone code screening assay capable of simultaneously detecting multiple hPTM-changes in human embryonic stem cells. We first validated the untargeted workflow with valproic acid (VPA), a histone deacetylase inhibitor. These results demonstrate the capability of mapping the hPTM-dynamics, with a general increase in acetylations as an internal control. To illustrate the scalability, a dose\u2013response study was performed on a proof-of-concept library of ten compounds (1) with a known effect on the hPTMs (BIX-01294, 3-Deazaneplanocin A, Trichostatin A, and VPA), (2) classified as highly embryotoxic by the European Centre for the Validation of Alternative Methods\u00a0(ECVAM) (Methotrexate, and All-trans retinoic acid), (3) classified as non-embryotoxic by ECVAM (Penicillin G), and (4) compounds of abuse with a presumed developmental toxicity (ethanol, caffeine, and nicotine).<\/jats:p>","DOI":"10.1038\/s41598-022-05268-x","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T11:03:57Z","timestamp":1643022237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A large scale mass spectrometry-based histone screening for assessing epigenetic developmental toxicity"],"prefix":"10.1038","volume":"12","author":[{"given":"Sigrid","family":"Verhelst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Van Puyvelde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Daled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senne","family":"Cornelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Corveleyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewoud","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Deforce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"De Clerck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Dhaenens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"key":"5268_CR1","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1042\/BST0381051","volume":"38","author":"D Laustriat","year":"2010","unstructured":"Laustriat, D., Gide, J. & Peschanski, M. Human pluripotent stem cells in drug discovery and predictive toxicology. Biochem. Soc. Trans. 38, 1051\u20131057 (2010).","journal-title":"Biochem. Soc. Trans."},{"key":"5268_CR2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tiv.2007.07.013","volume":"22","author":"S Adler","year":"2008","unstructured":"Adler, S., Pellizzer, C., Hareng, L., Hartung, T. & Bremer, S. First steps in establishing a developmental toxicity test method based on human embryonic stem cells. Toxicol. Vitro 22, 200\u2013211 (2008).","journal-title":"Toxicol. Vitro"},{"key":"5268_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00204-019-02613-4","volume":"94","author":"D Krewski","year":"2020","unstructured":"Krewski, D. et al. Toxicity testing in the 21st century: Progress in the past decade and future perspectives. Arch. Toxicol. 94, 1\u201358 (2020).","journal-title":"Arch. Toxicol."},{"key":"5268_CR4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.reprotox.2013.03.002","volume":"38","author":"AH Piersma","year":"2013","unstructured":"Piersma, A. H. et al. Evaluation of an alternative in vitro test battery for detecting reproductive toxicants. Reprod. Toxicol. 38, 53\u201364 (2013).","journal-title":"Reprod. Toxicol."},{"key":"5268_CR5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1248\/yakushi.127.491","volume":"127","author":"T Nakanishi","year":"2007","unstructured":"Nakanishi, T. The problem of species comparison of developmental toxicity: Can we extrapolate human developmental toxicity induced by environmental chemicals from the data of rodents?. Yakugaku Zasshi 127, 491\u2013500 (2007).","journal-title":"Yakugaku Zasshi"},{"key":"5268_CR6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/10937404.2010.483176","volume":"13","author":"D Krewski","year":"2010","unstructured":"Krewski, D. et al. Toxicity testing in the 21st century: A vision and a strategy. J. Toxicol. Environ. Health Part B Crit. Rev. 13, 51\u2013138 (2010).","journal-title":"J. Toxicol. Environ. Health Part B Crit. Rev."},{"key":"5268_CR7","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.fct.2017.09.014","volume":"109","author":"M Ideta-Otsuka","year":"2017","unstructured":"Ideta-Otsuka, M., Igarashi, K., Narita, M. & Hirabayashi, Y. Epigenetic toxicity of environmental chemicals upon exposure during development - Bisphenol A and valproic acid may have epigenetic effects. Food Chem. Toxicol. 109, 812\u2013816 (2017).","journal-title":"Food Chem. Toxicol."},{"key":"5268_CR8","doi-asserted-by":"publisher","unstructured":"Lauschke, V. M., Barragan, I. & Ingelman-Sundberg, M. Pharmacoepigenetics and Toxicoepigenetics: Novel Mechanistic Insights and Therapeutic Opportunities. (2017). https:\/\/doi.org\/10.1146\/annurev-pharmtox","DOI":"10.1146\/annurev-pharmtox"},{"key":"5268_CR9","doi-asserted-by":"crossref","unstructured":"Zhang, L., Lu, Q. & Chang, C. Epigenetics in Health and Disease. In Advances in Experimental Medicine and Biology vol. 1253 3\u201355 (Springer, 2020).","DOI":"10.1007\/978-981-15-3449-2_1"},{"key":"5268_CR10","doi-asserted-by":"publisher","unstructured":"McCullough, S. D. & Dolinoy, D. C. Toxicoepigenetics: Core Principles and Applications. Toxicoepigenetics: Core Principles and Applications (Elsevier, 2018). https:\/\/doi.org\/10.1016\/C2015-0-04098-9.","DOI":"10.1016\/C2015-0-04098-9"},{"key":"5268_CR11","doi-asserted-by":"publisher","unstructured":"Mochizuki, K. et al. Repression of germline genes by PRC1.6 and SETDB1 in the early embryo precedes DNA methylation-mediated silencing. (2021). https:\/\/doi.org\/10.21203\/rs.3.rs-400263\/v1.","DOI":"10.21203\/rs.3.rs-400263\/v1"},{"key":"5268_CR12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/38444","volume":"389","author":"K Luger","year":"1997","unstructured":"Luger, K., M\u00e4der, A. W., Richmond, R. K., Sargent, D. F. & Richmond, T. J. Crystal structure of the nucleosome core particle at 2.8 \u00c5 resolution. Nature 389, 251\u2013260 (1997).","journal-title":"Nature"},{"key":"5268_CR13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/biom7010003","volume":"7","author":"O Castillo-Aguilera","year":"2017","unstructured":"Castillo-Aguilera, O., Depreux, P., Halby, L., Arimondo, P. & Goossens, L. DNA methylation targeting: The DNMT\/HMT crosstalk challenge. Biomolecules 7, 3 (2017).","journal-title":"Biomolecules"},{"key":"5268_CR14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cbpa.2021.03.002","volume":"63","author":"IA Engelberg","year":"2021","unstructured":"Engelberg, I. A., Foley, C. A., James, L. I. & Frye, S. V. Improved methods for targeting epigenetic reader domains of acetylated and methylated lysine. Curr. Opin. Chem. Biol. 63, 132\u2013144 (2021).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"5268_CR15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1042\/BCJ20200170","volume":"478","author":"BC Taylor","year":"2021","unstructured":"Taylor, B. C. & Young, N. L. Combinations of histone post-Translational modifications. Biochem. J. 478, 511\u2013532 (2021).","journal-title":"Biochem. J."},{"key":"5268_CR16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575\u2013580 (2019).","journal-title":"Nature"},{"key":"5268_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01384-9","volume":"8","author":"J Simithy","year":"2017","unstructured":"Simithy, J. et al. Characterization of histone acylations links chromatin modifications with metabolism. Nat. Commun. 8, 1\u201313 (2017).","journal-title":"Nat. Commun."},{"key":"5268_CR18","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1074\/mcp.M115.053819","volume":"15","author":"Y Zheng","year":"2016","unstructured":"Zheng, Y. et al. Unabridged analysis of human histone H3 by differential top-down mass spectrometry reveals hypermethylated proteoforms from MMSET\/NSD2 overexpression. Mol. Cell. Proteom. 15, 776\u2013790 (2016).","journal-title":"Mol. Cell. Proteom."},{"key":"5268_CR19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/026119290203000205","volume":"30","author":"NA Brown","year":"2002","unstructured":"Brown, N. A. Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. ATLA Altern. Lab. Anim. 30, 177\u2013198 (2002).","journal-title":"ATLA Altern. Lab. Anim."},{"key":"5268_CR20","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1021\/acs.jproteome.9b00214","volume":"18","author":"L De Clerck","year":"2019","unstructured":"De Clerck, L. et al. HSWATH: Unlocking SWATH\u2019s full potential for an untargeted histone perspective. J. Proteome Res. 18, 3840\u20133849 (2019).","journal-title":"J. Proteome Res."},{"key":"5268_CR21","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.3390\/ijms21103721","volume":"21","author":"A Ornoy","year":"2020","unstructured":"Ornoy, A., Becker, M., Weinstein-Fudim, L. & Ergaz, Z. S-adenosine methionine (SAME) and valproic acid (VPA) as epigenetic modulators: Special emphasis on their interactions affecting nervous tissue during pregnancy. Int. J. Mol. Sci. 21, 3721 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"5268_CR22","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/bdra.23277","volume":"100","author":"K Fathe","year":"2014","unstructured":"Fathe, K., Palacios, A. & Finnell, R. H. Brief report novel mechanism for valproate-induced teratogenicity. Birth Defects Res Part A Clin. Mol. Teratol. 100, 592\u2013597 (2014).","journal-title":"Birth Defects Res Part A Clin. Mol. Teratol."},{"key":"5268_CR23","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"M G\u00f6ttlicher","year":"2001","unstructured":"G\u00f6ttlicher, M. et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 20, 6969\u20136978 (2001).","journal-title":"EMBO J."},{"key":"5268_CR24","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"CJ Phiel","year":"2001","unstructured":"Phiel, C. J. et al. Histone Deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276, 36734\u201336741 (2001).","journal-title":"J. Biol. Chem."},{"key":"5268_CR25","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1111\/febs.15248","volume":"287","author":"M Plazibat","year":"2020","unstructured":"Plazibat, M. et al. Embryo-derived teratoma in vitro biological system reveals antitumor and embryotoxic activity of valproate. FEBS J. 287, 4783\u20134800 (2020).","journal-title":"FEBS J."},{"key":"5268_CR26","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/jnr.20840","volume":"83","author":"A Hermann","year":"2006","unstructured":"Hermann, A. et al. Comparative analysis of neuroectodermal differentiation capacity of human bone marrow stromal cells using various conversion protocols. J. Neurosci. Res. 83, 1502\u20131514 (2006).","journal-title":"J. Neurosci. Res."},{"key":"5268_CR27","doi-asserted-by":"crossref","first-page":"1800186","DOI":"10.1002\/pmic.201800186","volume":"18","author":"F Limonier","year":"2018","unstructured":"Limonier, F. et al. Estimating the reliability of low-abundant signals and limited replicate measurements through MS2 peak area in SWATH. Proteomics 18, 1800186 (2018).","journal-title":"Proteomics"},{"key":"5268_CR28","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1074\/mcp.O113.036459","volume":"13","author":"S Lin","year":"2014","unstructured":"Lin, S. et al. Stable-isotope-labeled histone peptide library for histone post-translational modification and variant quantification by mass spectrometry. Mol. Cell. Proteom. 13, 2450 (2014).","journal-title":"Mol. Cell. Proteom."},{"key":"5268_CR29","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.3390\/ijms22042063","volume":"22","author":"F Cozzolino","year":"2021","unstructured":"Cozzolino, F., Iacobucci, I., Monaco, V., Angrisano, T. & Monti, M. Lysines acetylome and methylome profiling of H3 and H4 histones in trichostatin A-treated stem cells. Int. J. Mol. Sci. 22, 2063 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"5268_CR30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.stem.2018.10.017","volume":"24","author":"G van Mierlo","year":"2019","unstructured":"van Mierlo, G. et al. Integrative proteomic profiling reveals PRC2-dependent epigenetic crosstalk maintains ground-state pluripotency. Cell Stem Cell 24, 123-137.e8 (2019).","journal-title":"Cell Stem Cell"},{"key":"5268_CR31","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.celrep.2019.12.060","volume":"30","author":"C Alabert","year":"2020","unstructured":"Alabert, C. et al. Domain Model Explains Propagation Dynamics and Stability of Histone H3K27 and H3K36 Methylation Landscapes. Cell Rep. 30, 1223-1234.e8 (2020).","journal-title":"Cell Rep."},{"key":"5268_CR32","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.lfs.2007.07.030","volume":"81","author":"M Pal-Bhadra","year":"2007","unstructured":"Pal-Bhadra, M. et al. Distinct methylation patterns in histone H3 at Lys-4 and Lys-9 correlate with up- & down-regulation of genes by ethanol in hepatocytes. Life Sci. 81, 979\u2013987 (2007).","journal-title":"Life Sci."},{"key":"5268_CR33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.nbd.2013.01.022","volume":"54","author":"S Subbanna","year":"2013","unstructured":"Subbanna, S. et al. G9a-mediated histone methylation regulates ethanol-induced neurodegeneration in the neonatal mouse brain. Neurobiol. Dis. 54, 475\u2013485 (2013).","journal-title":"Neurobiol. Dis."},{"key":"5268_CR34","doi-asserted-by":"crossref","first-page":"19519","DOI":"10.1074\/jbc.M114.556555","volume":"289","author":"AM Urvalek","year":"2014","unstructured":"Urvalek, A. M. & Gudas, L. J. Retinoic acid and histone deacetylases regulate epigenetic changes in embryonic stem cells. J. Biol. Chem. 289, 19519\u201319530 (2014).","journal-title":"J. Biol. Chem."},{"key":"5268_CR35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tox.2014.03.011","volume":"321","author":"J Ping","year":"2014","unstructured":"Ping, J. et al. Prenatal caffeine ingestion induces aberrant DNA methylation and histone acetylation of steroidogenic factor 1 and inhibits fetal adrenal steroidogenesis. Toxicology 321, 53\u201361 (2014).","journal-title":"Toxicology"},{"key":"5268_CR36","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1158\/1535-7163.MCT-09-0013","volume":"8","author":"TB Miranda","year":"2009","unstructured":"Miranda, T. B. et al. DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Mol. Cancer Ther. 8, 1579\u20131588 (2009).","journal-title":"Mol. Cancer Ther."},{"key":"5268_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep38723","volume":"6","author":"IA Ciechomska","year":"2016","unstructured":"Ciechomska, I. A., Przanowski, P., Jackl, J., Wojtas, B. & Kaminska, B. BIX01294, an inhibitor of histone methyltransferase, induces autophagy-dependent differentiation of glioma stem-like cells. Sci. Rep. 6, 1\u201315 (2016).","journal-title":"Sci. Rep."},{"key":"5268_CR38","doi-asserted-by":"crossref","first-page":"17240","DOI":"10.1038\/s41598-019-53681-6","volume":"9","author":"L De Clerck","year":"2013","unstructured":"De Clerck, L. et al. Untargeted histone profiling during naive conversion uncovers conserved modification markers between mouse and human. Sci. Rep. 9, 17240 (2019).","journal-title":"Sci. Rep."},{"key":"5268_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-017-0028-1","volume":"9","author":"MT De Angelis","year":"2018","unstructured":"De Angelis, M. T., Parrotta, E. I., Santamaria, G. & Cuda, G. Short-term retinoic acid treatment sustains pluripotency and suppresses differentiation of human induced pluripotent stem cells. Cell Death Dis. 9, 1\u201313 (2018).","journal-title":"Cell Death Dis."},{"key":"5268_CR40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1741-7015-11-42","volume":"11","author":"V Sengpiel","year":"2013","unstructured":"Sengpiel, V. et al. Maternal caffeine intake during pregnancy is associated with birth weight but not with gestational length: Results from a large prospective observational cohort study. BMC Med. 11, 42 (2013).","journal-title":"BMC Med."},{"key":"5268_CR41","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/13576280310001607596","volume":"16","author":"JJ Guilbert","year":"2003","unstructured":"Guilbert, J. J. The world health report 2002\u2014Reducing risks, promoting healthy life [2]. Educ. Health 16, 230 (2003).","journal-title":"Educ. Health"},{"key":"5268_CR42","doi-asserted-by":"crossref","unstructured":"Lo, C. L. & Zhou, F. C. Environmental alterations of epigenetics prior to the birth. In International Review of Neurobiology vol. 115 1\u201349 (Academic Press Inc., 2014).","DOI":"10.1016\/B978-0-12-801311-3.00001-9"},{"key":"5268_CR43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/157015907781695955","volume":"5","author":"R Wickstrom","year":"2007","unstructured":"Wickstrom, R. Effects of nicotine during pregnancy: Human and experimental evidence. Curr. Neuropharmacol. 5, 213\u2013222 (2007).","journal-title":"Curr. Neuropharmacol."},{"key":"5268_CR44","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1017\/S1461145712001101","volume":"16","author":"KA Chase","year":"2013","unstructured":"Chase, K. A. & Sharma, R. P. Nicotine induces chromatin remodelling through decreases in the methyltransferases GLP, G9a, Setdb1 and levels of H3K9me2. Int. J. Neuropsychopharmacol. 16, 1129\u20131138 (2013).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"5268_CR45","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1080\/15592294.2019.1640546","volume":"14","author":"CL Miranda Furtado","year":"2019","unstructured":"Miranda Furtado, C. L. et al. Epidrugs: Targeting epigenetic marks in cancer treatment. Epigenetics 14, 1164\u20131176 (2019).","journal-title":"Epigenetics"},{"key":"5268_CR46","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.3389\/fonc.2020.605386","volume":"10","author":"M Montalvo-Casimiro","year":"2020","unstructured":"Montalvo-Casimiro, M. et al. Epidrug repurposing: Discovering new faces of old acquaintances in cancer therapy. Front. Oncol. 10, 2461 (2020).","journal-title":"Front. Oncol."},{"key":"5268_CR47","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12920-015-0095-z","volume":"8","author":"M Rasool","year":"2015","unstructured":"Rasool, M. et al. The role of epigenetics in personalized medicine: Challenges and opportunities. BMC Genomics 8, 24\u201327 (2015).","journal-title":"BMC Genomics"},{"key":"5268_CR48","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nmeth.2610","volume":"10","author":"H Hahne","year":"2013","unstructured":"Hahne, H. et al. DMSO enhances electrospray response, boosting sensitivity of proteomic experiments. Nat. Methods 10, 989\u2013991 (2013).","journal-title":"Nat. Methods"},{"key":"5268_CR49","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1373\/clinchem.2004.038489","volume":"50","author":"X Xu","year":"2004","unstructured":"Xu, X., Iba, M. M. & Weisel, C. P. Simultaneous and sensitive measurement of anabasine, nicotine, and nicotine metabolites in human urine by liquid chromatography\u2014Tandem mass spectrometry. Clin. Chem. 50, 2323\u20132330 (2004).","journal-title":"Clin. Chem."},{"key":"5268_CR50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-540-69248-5_2","volume":"192","author":"NL Benowitz","year":"2009","unstructured":"Benowitz, N. L., Hukkanen, J. & Jacob, P. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb. Exp. Pharmacol. 192, 29 (2009).","journal-title":"Handb. Exp. Pharmacol."},{"key":"5268_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-805455-0.00001-4","author":"A Dasgupta","year":"2017","unstructured":"Dasgupta, A. Alcohol a double-edged sword: Health benefits with moderate consumption but a health hazard with excess alcohol intake. Alcohol Drugs Genes Clin. Lab. https:\/\/doi.org\/10.1016\/B978-0-12-805455-0.00001-4 (2017).","journal-title":"Alcohol Drugs Genes Clin. Lab."},{"key":"5268_CR52","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.toxrep.2018.11.002","volume":"5","author":"C Willson","year":"2018","unstructured":"Willson, C. The clinical toxicology of caffeine: A review and case study. Toxicol. Reports 5, 1140\u20131152 (2018).","journal-title":"Toxicol. Reports"},{"key":"5268_CR53","first-page":"51","volume":"13","author":"E Genschow","year":"2000","unstructured":"Genschow, E. et al. Development of prediction models for three in vitro embryotoxicity tests in an ECVAM validation study. In Vitr. Mol. Toxicol. 13, 51\u201366 (2000).","journal-title":"In Vitr. Mol. Toxicol."},{"key":"5268_CR54","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cellbi.2008.08.012","volume":"32","author":"A Mehta","year":"2008","unstructured":"Mehta, A., Konala, V. B. R., Khanna, A. & Majumdar, A. S. Assessment of drug induced developmental toxicity using human embryonic stem cells. Cell Biol. Int. 32, 1412\u20131424 (2008).","journal-title":"Cell Biol. Int."},{"key":"5268_CR55","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/toxsci\/kfp012","volume":"108","author":"R Buesen","year":"2009","unstructured":"Buesen, R. et al. Embryonic stem cell test remastered: Comparison between the validated EST and the new molecular FACS-EST for assessing developmental toxicity in vitro. Toxicol. Sci. 108, 389\u2013400 (2009).","journal-title":"Toxicol. Sci."},{"key":"5268_CR56","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/bdrb.21078","volume":"98","author":"JA Palmer","year":"2013","unstructured":"Palmer, J. A. et al. Establishment and assessment of a new human embryonic stem cell-based biomarker assay for developmental toxicity screening. Birth Defects Res Part B Dev. Reprod. Toxicol. 98, 343\u2013363 (2013).","journal-title":"Birth Defects Res Part B Dev. Reprod. Toxicol."},{"key":"5268_CR57","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.biocel.2008.08.020","volume":"41","author":"A Mai","year":"2009","unstructured":"Mai, A. & Altucci, L. Epi-drugs to fight cancer: From chemistry to cancer treatment, the road ahead. Int. J. Biochem. Cell Biol. 41, 199\u2013213 (2009).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"5268_CR58","unstructured":"Mode of Action: Inhibition of Histone Deacetylase, Altering WNT-Dependent Gene Expression, and Regulation of Beta-Catenin-Developmental Effects of Valproic Acid\u2014ProQuest. https:\/\/www.proquest.com\/docview\/218864806?accountid=11077."},{"key":"5268_CR59","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/bdrb.21132","volume":"101","author":"GP Daston","year":"2014","unstructured":"Daston, G. P. et al. Exposure-based validation list for developmental toxicity screening assays. Birth Defects Res. Part B Dev. Reprod. Toxicol. 101, 423\u2013428 (2014).","journal-title":"Birth Defects Res. Part B Dev. Reprod. Toxicol."},{"key":"5268_CR60","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00204-014-1279-6","volume":"88","author":"NV Balmer","year":"2014","unstructured":"Balmer, N. V. et al. From transient transcriptome responses to disturbed neurodevelopment: Role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch. Toxicol. 88, 1451\u20131468 (2014).","journal-title":"Arch. Toxicol."},{"key":"5268_CR61","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1093\/hmg\/dds239","volume":"21","author":"NV Balmer","year":"2012","unstructured":"Balmer, N. V. et al. Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome. Hum. Mol. Genet. 21, 4104\u20134114 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"5268_CR62","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/toxsci\/kfaa014","volume":"174","author":"TJ Zurlinden","year":"2020","unstructured":"Zurlinden, T. J. et al. Profiling the ToxCast library with a pluripotent human (H9) stem cell line-based biomarker assay for developmental toxicity. Toxicol. Sci. 174, 189\u2013209 (2020).","journal-title":"Toxicol. Sci."},{"key":"5268_CR63","unstructured":"Drug Toxicity in Embryonic Development II: Advances in Understanding ... - Robert J. Kavlock, George P. Daston - Google Boeken. https:\/\/books.google.be\/books?id=vcHsCAAAQBAJ&pg=PA20&lpg=PA20&dq=retinoic+acid+IC50+teratogen&source=bl&ots=rHD-9p68aK&sig=vwFQ-4_3JZMearS5dME3LUK5hiA&hl=nl&sa=X&ved=0ahUKEwiNw6aiu5vPAhViAsAKHYIEDrAQ6AEILzAC#v=onepage&q=retinoicacidIC50teratogen&f=false."},{"key":"5268_CR64","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.reprotox.2017.07.011","volume":"73","author":"JA Palmer","year":"2017","unstructured":"Palmer, J. A. et al. A human induced pluripotent stem cell-based in vitro assay predicts developmental toxicity through a retinoic acid receptor-mediated pathway for a series of related retinoid analogues. Reprod. Toxicol. 73, 350\u2013361 (2017).","journal-title":"Reprod. Toxicol."},{"key":"5268_CR65","unstructured":"Rifai, N., Horvath, A. R. (Andrea R. & Wittwer, C. (Carl). Tietz textbook of clinical chemistry and molecular diagnostics. 1284."},{"key":"5268_CR66","unstructured":"MTHX - Overview: Methotrexate, Serum. https:\/\/www.mayocliniclabs.com\/test-catalog\/overview\/37047#Clinical-and-Interpretive."},{"key":"5268_CR67","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.lungcan.2012.08.003","volume":"78","author":"J Kikuchi","year":"2012","unstructured":"Kikuchi, J. et al. Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells. Lung Cancer 78, 138\u2013143 (2012).","journal-title":"Lung Cancer"},{"key":"5268_CR68","first-page":"73","volume":"2","author":"S Azghadi","year":"2011","unstructured":"Azghadi, S. & Clark, A. T. Epigenetically reprogramming of human embryonic stem cells by 3-deazaneplanocin A and sodium butyrate. Int. J. Prev. Med. 2, 73 (2011).","journal-title":"Int. J. Prev. Med."},{"key":"5268_CR69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-6-59","volume":"6","author":"DR Santillano","year":"2005","unstructured":"Santillano, D. R. et al. Ethanol induces cell-cycle activity and reduces stem cell diversity to alter both regenerative capacity and differentiation potential of cerebral cortical neuroepithelial precursors. BMC Neurosci. 6, 1\u201317 (2005).","journal-title":"BMC Neurosci."},{"key":"5268_CR70","first-page":"662","volume":"125","author":"LC Sun","year":"2012","unstructured":"Sun, L. C. et al. Nicotine inhibits histone deacetylase 6 activity and chaperone-dependent activation of the glucocorticoid receptor in A549 cells. Chin. Med. J. (Engl.) 125, 662\u2013666 (2012).","journal-title":"Chin. Med. J. (Engl.)"},{"key":"5268_CR71","doi-asserted-by":"publisher","unstructured":"Vossaert, L. et al. Reference loci for RT-qPCR analysis of differentiating human embryonic stem cells. http:\/\/www.biomedcentral.com\/1471-2199\/14\/21 (2013). https:\/\/doi.org\/10.1186\/1471-2199-14-21.","DOI":"10.1186\/1471-2199-14-21"},{"key":"5268_CR72","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/pmic.201500231","volume":"16","author":"NV Bhanu","year":"2016","unstructured":"Bhanu, N. V., Sidoli, S. & Garcia, B. A. Histone modification profiling reveals differential signatures associated with human embryonic stem cell self-renewal and differentiation. Proteomics 16, 448\u2013458 (2016).","journal-title":"Proteomics"},{"key":"5268_CR73","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1002\/dvdy.21773","volume":"237","author":"E B\u00e1rtov\u00e1","year":"2008","unstructured":"B\u00e1rtov\u00e1, E. et al. Epigenome and chromatin structure in human embryonic stem cells undergoing differentiation. Dev. Dyn. 237, 3690\u20133702 (2008).","journal-title":"Dev. Dyn."},{"key":"5268_CR74","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/stem.59","volume":"27","author":"A Golebiewska","year":"2009","unstructured":"Golebiewska, A., Atkinson, S. P., Lako, M. & Armstrong, L. Epigenetic landscaping during hESC differentiation to neural cells. Stem Cells 27, 1298\u20131308 (2009).","journal-title":"Stem Cells"},{"key":"5268_CR75","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.devcel.2013.03.002","volume":"25","author":"Y Wang","year":"2013","unstructured":"Wang, Y. et al. Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev. Cell 25, 69\u201380 (2013).","journal-title":"Dev. Cell"},{"key":"5268_CR76","doi-asserted-by":"crossref","first-page":"33853","DOI":"10.18632\/oncotarget.26127","volume":"9","author":"S Bakshi","year":"2018","unstructured":"Bakshi, S., McKee, C., Walker, K., Brown, C. & Rasul Chaudhry, G. Toxicity of JQ1 in neuronal derivatives of human umbilical cord mesenchymal stem cells. Oncotarget 9, 33853\u201333864 (2018).","journal-title":"Oncotarget"},{"key":"5268_CR77","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1002\/pmic.201400569","volume":"15","author":"P Meert","year":"2015","unstructured":"Meert, P., Govaert, E., Scheerlinck, E., Dhaenens, M. & Deforce, D. Pitfalls in histone propionylation during bottom-up mass spectrometry analysis. Proteomics 15, 2966\u20132971 (2015).","journal-title":"Proteomics"},{"key":"5268_CR78","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/pmic.201600341","volume":"16","author":"E Govaert","year":"2016","unstructured":"Govaert, E. et al. Extracting histones for the specific purpose of label-free MS. Proteomics 16, 2937\u20132944 (2016).","journal-title":"Proteomics"},{"key":"5268_CR79","doi-asserted-by":"crossref","first-page":"101055","DOI":"10.1016\/j.mex.2020.101055","volume":"7","author":"S Verhelst","year":"2020","unstructured":"Verhelst, S. et al. Comprehensive histone epigenetics: A mass spectrometry based screening assay to measure epigenetic toxicity. MethodsX 7, 101055 (2020).","journal-title":"MethodsX"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05268-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05268-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05268-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T21:08:44Z","timestamp":1669324124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05268-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5268"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-05268-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]},"assertion":[{"value":"5 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1256"}}